# P2 Science

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/p2-science

- Industry: Chemicals
- Headquarters: New Haven, US
- Website: www.p2science.com
- Total disclosed funding: $36M
- Latest round: Series C (Feb 21, 2023)
- Investors on record: 10

## About

P2 Science, Inc., based in New Haven, US, focuses on developing sustainable, high-performance ingredients for various industries, including beauty and personal care, utilizing innovative technologies to promote environmental sustainability. Founded in 2011 in New Haven, US, P2 Science, Inc. specializes in sustainable ingredient development. In May 2026, P2 Science, Inc. raised USD 23 million in venture funding led by Sofinnova Partners, with participation from Emerald Technology Ventures, GS Futures, Lewis & Clark Ventures, DSM Venturing, Connecticut Innovations, Elm Street Ventures, CHANEL S.A., BASF, and Safer Made.

The CEO is Oihana Elizalde, and the company was founded by Patrick Foley, who has a history of entrepreneurial ventures. P2 Science Inc. specializes in developing and commercializing sustainable, high-performance ingredients for the beauty, personal care, crop care, textiles, and advanced materials sectors. Their core product, Citropol®, is a patented line of liquid polymers derived from natural pine oil, aimed at replacing traditional petroleum-based emollients in cosmetic applications. Additionally, P2 Science employs proprietary technologies like PIOz™ and PICE™ to create innovative aroma materials and plant-based crop protection solutions, serving clients across 25 countries, including major brands in the US, Europe, and Asia.P2 Science operates a revenue model based on partnerships and direct sales of its innovative product lines to brands and manufacturers within its target markets. Engaging in B2B transactions, the company provides sustainable ingredients such as Citropol® under defined contractual agreements, allowing for predictable revenue streams. Collaborations with industry leaders for joint development projects further enhance its revenue potential, with pricing structures based on product performance and sustainability attributes. 

The company will use the May 2026 funding to scale production of its renewable chemicals, support recent product launches, and expand its biomaterials partnership.

## Funding rounds

- Series C, Feb 21, 2023, $13M — BASF, Elm Street Ventures, Lewis & Clark Ventures, HG Ventures, CHANEL S.A., Safer Made
- Series C, Jan 28, 2020, $12M — HG Ventures, CHANEL S.A., Safer Made
- Series B, Mar 1, 2017, $9.6M — Advantage Capital, Ironwood Capital, Connecticut Innovations, BASF, Elm Street Ventures, Xeraya Capital
- Series A, Apr 3, 2014, $1M — Connecticut Innovations, Elm Street Ventures
- Seed, May 19, 2013, $0.7M — Connecticut Innovations, Elm Street Ventures

## Investors

- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Seed, Series A, Series B
- Elm Street Ventures (https://capitalatlas.ai/funds/elm-street-ventures) — Seed, Series A, Series B, Series C
- Advantage Capital — Series B
- Ironwood Capital (https://capitalatlas.ai/funds/ironwood-capital) — Series B
- BASF (https://capitalatlas.ai/funds/basf) — Series B, Series C
- Xeraya Capital (https://capitalatlas.ai/funds/xeraya-capital) — Series B
- HG Ventures (https://capitalatlas.ai/funds/hg-ventures) — Series C
- CHANEL S.A. — Series C
- Safer Made (https://capitalatlas.ai/funds/safer-made) — Series C
- Lewis & Clark Ventures (https://capitalatlas.ai/funds/lewis-clark-ventures) — Series C